1Felker GM, Shaw LK, O'Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research[J]. J Am Coll Cardiol, 2002, 39(2) :210-218.
2Guyatt G, Sullivan M, Thompson P, et al. The 6-minute walk test: a new measure of exercise capacity in patients with chronic heart failure[J]. Can Med Assoc J, 1985,132:919-923.
3Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to cnalapril or placebo[ J]. Am J Cardiol, 1993,71 : 1 106.
4Opasich C, Pinna G, Mazza A,et al. Six-minute walking performance in patients with moderate-to-severe heart failure[J]. Eur Heart J, 2001,22 : 488-496.
5Task force for the diagnosis and treatment of chronic heart failure,European society of cardiology. Guidelines for the diagnosis and treatment of chronic heart failure [J]. Eur Heart J, 2001, 22(17):1527.
6Lee DC, Johnson RA, Bingham JB, et at. Heart failure in out patients:A randomized trial of digoxin versus placebo[J]. N Engl J Med,1998,338(12):306.
7Sedian R, Loebe M, Schmitt C, et al. Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems [J]. J Am Coll Cardiol, 2001, 38(7):1942.
8Klappacher G, Fransen P, Haab D, et al. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis [J]. Am J Cardiol, 1995,75(14):913.
